1 – 4 of 4
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Key Device Attributes for Injectable Somatostatin Receptor Ligand Therapy in Acromegaly and Neuroendocrine Tumours
(
- Contribution to journal › Article
- 2014
-
Mark
Adult mortality or morbidity is not increased in childhood-onset growth hormone deficient patients who received pediatric GH treatment: an analysis of the Hypopituitary Control and Complications Study (HypoCCS)
(
- Contribution to journal › Article
- 2013
-
Mark
Prospective Safety Surveillance of GH-Deficient Adults: Comparison of GH-Treated vs Untreated Patients.
(
- Contribution to journal › Article
- 2009
-
Mark
Changing patterns of the adult growth hormone deficiency diagnosis documented in a decade-long global surveillance database
(
- Contribution to journal › Article